BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 31640765)

  • 21. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.
    Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.
    Liu W; Zhao L; Blackman B; Parmar M; Wong MY; Woo T; Yu F; Chiuchiolo MJ; Sondhi D; Kaminsky SM; Crystal RG; Paul SM
    J Neurosci; 2016 Dec; 36(49):12425-12435. PubMed ID: 27927959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.
    Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R
    J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted downregulation of dMyc restricts neurofibrillary tangles mediated pathogenesis of human neuronal tauopathies in Drosophila.
    Chanu SI; Sarkar S
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2111-2119. PubMed ID: 28529046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered Proteostasis in Neurodegenerative Tauopathies.
    Papanikolopoulou K; Skoulakis EMC
    Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
    Mewes A; Franke H; Singer D
    PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.
    Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N
    Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interneuronal transfer of human tau between Lamprey central neurons in situ.
    Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF
    J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
    Robert A; Schöll M; Vogels T
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
    Front Immunol; 2020; 11():997. PubMed ID: 32508844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
    Vagnozzi AN; Giannopoulos PF; Praticò D
    Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.
    Rodríguez-Navarro JA; Rodríguez L; Casarejos MJ; Solano RM; Gómez A; Perucho J; Cuervo AM; García de Yébenes J; Mena MA
    Neurobiol Dis; 2010 Sep; 39(3):423-38. PubMed ID: 20546895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
    Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
    J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
    Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
    J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes.
    Goodwin MS; Sinyavskaya O; Burg F; O'Neal V; Ceballos-Diaz C; Cruz PE; Lewis J; Giasson BI; Davies P; Golde TE; Levites Y
    Mol Ther; 2021 Feb; 29(2):859-872. PubMed ID: 33128896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
    Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
    Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
    Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.
    Planel E; Bretteville A; Liu L; Virag L; Du AL; Yu WH; Dickson DW; Whittington RA; Duff KE
    FASEB J; 2009 Aug; 23(8):2595-604. PubMed ID: 19279139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
    Fox LM; William CM; Adamowicz DH; Pitstick R; Carlson GA; Spires-Jones TL; Hyman BT
    J Neuropathol Exp Neurol; 2011 Jul; 70(7):588-95. PubMed ID: 21666499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.